Clinicophysiological outcomes after total pancreatectomy

被引:16
|
作者
Suzuki, Shuji [1 ,2 ]
Miura, Junnosuke [3 ]
Shimizu, Kyoko [4 ]
Tokushige, Katsutoshi [4 ]
Uchigata, Yasuko [3 ]
Yamamoto, Masakazu [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Surg Gastroenterol, Tokyo, Japan
[2] Tokyo Med Univ, Ibaraki Med Ctr, Dept Surg Gastroenterol, 3-20-1 Chuo, Amimachi, Ibaraki 3000395, Japan
[3] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan
[4] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo, Japan
关键词
Total pancreatectomy; pancreatic neoplasms; glycemic control; synthetic insulin; pancreatic enzyme; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; HEPATIC STEATOSIS; INSULIN; ADENOCARCINOMA; PANCREAS; PANCRELIPASE; NEOPLASMS; RESECTION; CANCER;
D O I
10.1080/00365521.2016.1211173
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: Total pancreatectomy (TP) for pancreatic neoplasms is associated with high morbidity and mortality rates. However, with recent advances in surgical techniques and improved postoperative management, the number of cases with clinical indications for TP is increasing. Here, we evaluated the clinical outcomes post-TP.Materials and methods: Patients (n=41) who underwent TP between 2004 and 2011 at Tokyo Women's Medical University were retrospectively examined. Pre- and postoperative clinicophysiological data were collected up to 12 months post-TP and then analyzed.Results: Only glycated hemoglobin (HbA1c), percentage of lymphocytes and hepatic Hounsfield unit level on computed tomography (CT) were significantly different between the preoperative state and at 12 months post-TP, while other clinicophysiological parameters remained unchanged. The quantity of the pancreatic enzyme administered significantly influenced glycemic control at 12 months post-TP (p<0.05).Conclusions: All clinicophysiological parameters except for HbA1c were temporarily decreased after TP but normalized by 12 months. Thus, TP is a feasible surgical approach to treating pancreatic neoplasms with the potential to spread across the entire pancreas when adequately supplemented by synthetic insulin and pancreatic enzymes.
引用
收藏
页码:1526 / 1531
页数:6
相关论文
共 50 条
  • [1] The Clinical Outcomes after Total Pancreatectomy
    Suzuki, Shuji
    Kajiyama, Hideki
    Takemura, Akira
    Shimazaki, Jiro
    Nishida, Kiyotaka
    Shimoda, Mitsugi
    DIGESTIVE SURGERY, 2017, 34 (02) : 142 - 150
  • [2] Patient outcomes after total pancreatectomy: a single centre contemporary experience
    Stauffer, John A.
    Nguyen, Justin H.
    Heckman, Michael G.
    Grewal, Manpreet S.
    Dougherty, Marjorie
    Gill, Kanwar R. S.
    Jamil, Laith H.
    Scimeca, Daniela
    Raimondo, Massimo
    Smith, C. Daniel
    Martin, J. Kirk
    Asbun, Horacio J.
    HPB, 2009, 11 (06) : 483 - 492
  • [3] Changes in the body composition and nutritional status after total pancreatectomy
    Uemura, Masao
    Ohgi, Katsuhisa
    Sugiura, Teiichi
    Okamura, Yukiyasu
    Ito, Takaaki
    Yamamoto, Yusuke
    Ashida, Ryo
    Aramaki, Takeshi
    Notsu, Akifumi
    Kawabata, Takanori
    Uesaka, Katsuhiko
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (06) : 1909 - 1916
  • [4] Long-Term Outcomes After Total Pancreatectomy and Islet Cell Autotransplantation Is It a Durable Operation?
    Wilson, Gregory C.
    Sutton, Jeffrey M.
    Abbott, Daniel E.
    Smith, Milton T.
    Lowy, Andrew M.
    Matthews, Jeffrey B.
    Rilo, Horacio L. R.
    Schmulewitz, Nathan
    Salehi, Marzieh
    Choe, Kyuran
    Brunner, John
    Hanseman, Dennis J.
    Sussman, Jeffrey J.
    Edwards, Michael J.
    Ahmad, Syed A.
    ANNALS OF SURGERY, 2014, 260 (04) : 659 - 667
  • [5] Contemporary report of surgical outcomes after single-stage total pancreatectomy: A 10-year experience
    Zohar, Nitzan
    Kowal, Luke
    Moskal, David
    Ponzini, Francesca
    Sun, George
    Lamm, Ryan J.
    Williamson, John
    Nevler, Avinoam
    Lavu, Harish
    Maley, Warren R.
    Yeo, Charles J.
    Bowne, Wilbur B.
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (07) : 1235 - 1244
  • [6] Residual total pancreatectomy: Short- and long-term outcomes
    Hashimoto, Daisuke
    Chikamoto, Akira
    Taki, Katsunobu
    Arima, Kota
    Yamashita, Yo-ichi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Baba, Hideo
    PANCREATOLOGY, 2016, 16 (04) : 646 - 651
  • [7] Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy
    Shi, Hao-Jun
    Jin, Chen
    Fu, De-Liang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (02) : 265 - 274
  • [8] Are there still indications for total pancreatectomy?
    Del Chiaro, Marco
    Rangelova, Elena
    Segersvard, Ralf
    Arnelo, Urban
    UPDATES IN SURGERY, 2016, 68 (03) : 257 - 263
  • [9] Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature
    Parsaik, Ajay K.
    Murad, Mohammad Hassan
    Sathananthan, Airani
    Moorthy, Vetriselvi
    Erwin, Patricia J.
    Chari, Suresh
    Carter, Rickey E.
    Farnell, Michael B.
    Vege, S. S.
    Sarr, Michael G.
    Kudva, Yogish C.
    CLINICAL ENDOCRINOLOGY, 2010, 73 (06) : 723 - 731
  • [10] Contemporary indications for upfront total pancreatectomy
    Casadei, Riccardo
    Ricci, Claudio
    Ingaldi, Carlo
    Alberici, Laura
    Minni, Francesco
    UPDATES IN SURGERY, 2021, 73 (04) : 1205 - 1217